DMT is famous for producing intense, otherworldly psychedelic experiences when taken in large doses. New research out of Hungary suggests it may also be one of the body’s own tools for limiting damage after a stroke.
The study, published in Science Advances by a team at the HUN-REN BRC Institute of Biophysics and Semmelweis University, builds on earlier work showing that DMT reduces the size of brain injury in a rat model of stroke. This time, the researchers wanted to know why.
What they found points to a molecule working two separate jobs at once: patching up the brain’s protective barrier, and calming the inflammation that follows a stroke.
Barrier break down
The blood-brain barrier is a tightly regulated layer of cells that normally keeps the bloodstream’s contents out of sensitive brain tissue. During a stroke, that barrier tends to fail, letting proteins and immune cells flood into the brain and make the damage worse. Much of the secondary harm from a stroke, the kind that persists well after blood flow is restored, traces back to this breakdown.
In the rat model, DMT treatment significantly reduced infarct volume (the size of the damaged brain region) and the swelling, or edema, that comes with it. Looking more closely, the researchers found that DMT helped preserve claudin-5, a key protein that holds the barrier’s cells together, and reduced the leakage of albumin, a blood protein, into both brain tissue and cerebrospinal fluid.
In cell culture experiments simulating the oxygen and glucose deprivation of a stroke, DMT produced a similar protective effect on cultured brain endothelial cells, the cells that form the barrier itself.
Calming the immune response
The second half of the story involves inflammation. After a stroke, damaged brain tissue releases signals that activate the immune system, both locally in the brain and throughout the body. This response is meant to help, but it often overshoots, and the resulting inflammation contributes heavily to lasting damage.
DMT treatment lowered levels of several inflammatory cytokines (TNFα, IL-1β, IL-6, and related chemokines) in the blood, while raising levels of the anti-inflammatory cytokine IL-10 and the neuroprotective protein BDNF. It also held back the activation of microglia, the brain’s resident immune cells, keeping more of them in their calmer, “surveying” state rather than the reactive, damage-associated state they tend to shift into after injury.
Following the receptor
Much of this protective effect appears to run through the sigma-1 receptor, a receptor DMT is known to activate naturally in the body. When the researchers gave a sigma-1 receptor blocker (called BD1063) alongside DMT, several of the protective effects, on lesion size, cytokine levels, and microglial activation, were weakened or erased.
That said, not everything reversed. DMT’s effects on barrier permeability and on certain blood markers held up even with the receptor blocked, suggesting the sigma-1 receptor is an important piece of the puzzle, but not the whole mechanism.
Limitations
It’s worth being precise about what this study does and doesn’t show. This is preclinical work on rats and cultured cells, not people. The infarct-reducing effect of DMT in this rat stroke model had already been shown in earlier research, but what’s new here is a plausible explanation for how it happens.
That said, this isn’t a purely speculative finding sitting in isolation. DMT is already in human clinical trials for stroke recovery, including a completed phase 1 trial and a planned phase 2 trial examining its effects on neuroplasticity and long-term recovery.
This mechanistic study gives researchers something concrete to build on as those trials continue, and it helps explain why a treatment that showed promise in earlier work might actually be working.
A new story about DMT
Most conversations about DMT center on consciousness: the entities, the geometric visions, the sense of dying and being reborn in five minutes. This research tells the other side of the story – one about brain health, inflammation and immune response.
But it fits a pattern we keep returning to at The Spore Report. Molecules that shape consciousness often turn out to be doing beneficial biological work behind the scenes.
DMT sits in this odd dual role, as both a trigger for some of the most intense subjective experiences humans can have, and, possibly, as a built-in repair mechanism the brain reaches for when it’s under threat.
Follow the research here.
